Bafna Pharmaceuticals Q1 Results
- BSE: 532989
- NSE: BAFNAPH
- ISIN: INE878I01022
- Sector: Biotechnology & Drugs
BSE
408.55
8.00 (2.00%)
8.00 (2.00%)Volume5.01 K
Updated: Wed 7 Oct, 2026 | 15:15:00
NSE
401.857.85 (1.99%)
7.85 (1.99%)Volume956.00
Updated: Wed 7 Oct, 2026 | 15:14:46
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q1 Results Highlights
- Total Income₹26.58 Cr.(-23.22%)
- Operating Profit₹-0.90 Cr.(NA%)
- Profit After Tax₹0.08 Cr.(-97.78%)
- Operating Margin-3.38%(NA%)
Note: Comparison is on YoY basis
Quarterly - Bafna Pharmaceuticals Q1 Results
*All figures in crores except per share values
| Fiscal Period | Jun 26 | Mar 26 | QoQ Comp | Jun 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 27.48 | 40.35 | -31.89% | 33.86 | -11.13% |
| Depreciation/ Amortization | 1.78 | 1.66 | 7.27% | 1.44 | 29.99% |
| Operating Income | -0.90 | 1.89 | 0.00% | -0.58 | 0.00% |
| Net Income | 0.08 | 2.75 | -97.27% | -0.72 | -97.78% |
| Other Operating Expenses Total | 2.59 | 3.51 | -26.34% | 1.84 | 72.73% |
| Net Income Before Taxes | 0.08 | 2.62 | -97.13% | -0.72 | -97.78% |
| Total Revenue | 26.58 | 42.24 | -37.07% | 33.29 | -23.22% |
| Selling/ General/ Admin Expenses Total | 5.62 | 5.44 | 3.18% | 5.14 | -0.42% |
| Diluted Normalized EPS | 0.03 | 1.11 | -97.29% | -0.16 | -97.90% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.